Evidence map›Paper›PMID 38896292›Full record

ArticleMikrochimica acta2024

A label-free and rapid fluorometric strategy for microRNA detection using CRISPR-Cas12a coupled with copper nanoparticles.

Shirong Wang, Zaiwa Wei, Liangxian Li, Yu Luo, Zhimei Huang, Xing Yang, Yafang Tang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shirong WangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, China.
Zaiwa WeiThe First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Liangxian LiKey Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin, Guangxi, China.
Yu LuoClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, China.
Zhimei HuangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, China.
Xing YangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, China.
Yafang TangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, China. tangavonrs@163.com.ORCID http://orcid.org/0009-0002-9984-2306

Funding

Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi 2020KY12012Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi 2023KY0522Natural Science Foundation of Guangxi Province 2021GXNSFBA076001
6 · The paper itself

Abstract

CRISPR-Cas12a with robust trans-cleavage activity were employed to mitigate background fluorescence signal, achieving sensitive detection of miRNA-21. The activation of trans-cleavage activity of Cas12a was achieved by utilizing cDNA as a trigger. Upon the presence of target miRNA-21, cDNA hybridizes with it forming a DNA/RNA double-stranded structure. Exonuclease III (ExoIII) facilitates the degradation of cDNA, releasing the target for subsequent cycles. Due to cDNA degradation, the trans-cleavage activity of Cas12a remains unactivated and does not disrupt the synthesis template of copper nanoparticles. Addition of Cu

Indexed as

CopperCRISPR-Cas SystemsLimit of DetectionMetal NanoparticlesMicroRNAsBacterial ProteinsBiosensing TechniquesCRISPR-Associated ProteinsEndodeoxyribonucleasesFluorometryHumansBacterial ProteinsCas12a proteinCopperCRISPR-Associated ProteinsEndodeoxyribonucleasesMicroRNAsMIRN21 microRNA, humanCRISPR-Cas12aDNA-CuNPsFluorescent biosensingmiRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.